Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | FASN | P49327 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | PRKCA | P17252 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6834489 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL6836168 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL2526147 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL1022882 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL6718004 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL6267257 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL2525302 | 1.00 | TYR (0.41) | TYRPOLBFASNCYP1A2PRKCA | |
| SCHEMBL6834784 | 0.90 | ALDH1A1 (0.48) | TYRPOLBCYP1A2TP53ALDH1A1 | |
| SCHEMBL10998132 | 0.84 | TP53 (0.44) | POLBFASNCYP1A2PRKCATP53 | |
| SCHEMBL31134790 | 0.84 | TP53 (0.44) | POLBFASNCYP1A2PRKCATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088923-B2 | Cyclic-fused beta-lactones and their synthesis | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088923-B2 | Cyclic-fused beta-lactones and their synthesis | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2012-01-03 | — | — | US | disclosed |
| US-20090062547-A1 | CYCLIC-FUSED BETA-LACTONES AND THEIR SYNTHESIS | THE TEXAS A&M UNIVERSITY SYSTEM | 2009-03-05 | — | — | US | disclosed |
| US-20090062547-A1 | CYCLIC-FUSED BETA-LACTONES AND THEIR SYNTHESIS | THE TEXAS A&M UNIVERSITY SYSTEM | 2009-03-05 | — | — | US | disclosed |
| US-6750189-B1 | ONE OR MORE LYSINE AND/OR ORNITHINE BASED POLYMERS WHICH PROVIDE ENHANCED FABRIC APPEARANCE BENEFITS | THE PROCTER & GAMBLE COMPANY | 2004-06-15 | — | — | US | disclosed |
| EP-1153119-A1 | FABRIC ENHANCEMENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-14 | — | — | EP | disclosed |
| US-6214786-B1 | MIXTURE OF SURFACTANTS AND POLYMERS FOR DETERGENTS | THE PROCTER & GAMBLE COMPANY | 2001-04-10 | — | — | US | disclosed |
| CN-1273596-A | Laundry detergent compositions with amino acid based polymers for providing appearance and integrity benefits to laundered fabrics | PROCTER & GAMBLE (US) | 2000-11-15 | — | — | CN | disclosed |
| WO-2000049125-A1 | FABRIC ENHANCEMENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-24 | — | — | WO | disclosed |
| EP-1009790-A1 | LAUNDRY DETERGENT COMPOSITIONS WITH AMINO ACID BASED POLYMERS TO PROVIDE APPEARANCE AND INTEGRITY BENEFITS TO FABRICS LAUNDERED THEREWITH | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-21 | — | — | EP | disclosed |
| US-6034204-A | Condensation products of basic amino acids with copolymerizable compounds and a process for their production | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-07 | — | — | US | disclosed |
| WO-1999007813-A1 | LAUNDRY DETERGENT COMPOSITIONS WITH AMINO ACID BASED POLYMERS TO PROVIDE APPEARANCE AND INTEGRITY BENEFITS TO FABRICS LAUNDERED THEREWITH | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-18 | — | — | WO | disclosed |
| CN-1142776-A | Hirudin conjugates from hirudin and lipophilic compounds | BASF AG (DE) | 1997-02-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062547-A1 | CYCLIC-FUSED BETA-LACTONES AND THEIR SYNTHESIS | COASY, FASN, OTUB1 | TYR 4734/4885POLB 1344/4885FASN 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.